Claude J. Migeon
Johns Hopkins University
338 Papers
6.8K Citations
Claude J. Migeon is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Androgen & Congenital adrenal hyperplasia. The author has an hindex of 71, co-authored 338 publications. Previous affiliations of Claude J. Migeon include Wright State University & Stony Brook University.
Chat about Author
Papers
•Journal Article
Gender identity/role differentiation in adolescents affected by syndromes of abnormal sex differentiation.
TL;DR: It is hoped that adolescents with intersex conditions will have the support and information necessary to allow them to live as normal a life as possible.
11
Effect of various ACTH preparations and of metyrapone on the secretion of growth hormone in normal subjects and in hypopituitary patients.
TL;DR: The children, whether normal or hypopituitary, showed no growth hormone increase following administration of any of the ACTH preparations, and neither oral (750 mg) nor iv (7.5 mg/kg/hr) metyrapone administration was followed by growth hormone release in adult subjects with increased compound S concentrations indicative of endogenous ACTH release.
10
Ovarian hyperthecosis in the adolescent patient.
TL;DR: The finding of low serum LH values in patients with hirsutism and elevated androgen secretion should alert the clinician to the possibility of a tumor.
10
9 Androgen receptors
TL;DR: The influence of androgen receptor function in the pathogenesis of benign prostatic hypertrophy is being investigated and Androgen receptor content is also being studied as a possible marker of responsiveness to hormonal therapy in prostatic carcinoma.
10
Serum 3α-Androstanediol Glucuronide Measurements in Sexually Mature Women with Congenital Adrenal Hyperplasia during Therapy*
TL;DR: The excellent correlation between the serum 3 alpha-diol G levels and standard measures of control indicates that the former measurement may be a useful adjunct in the management of women with congenital adrenal hyperplasia and underscores the validity of serum 3 Alpha-Diol G measurements as indicators of androgen production and metabolism in women.
10